A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals
- PMID: 32492105
- DOI: 10.1001/jama.2020.10218
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals
Comment on
-
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.JAMA. 2020 Aug 4;324(5):460-470. doi: 10.1001/jama.2020.10044. JAMA. 2020. PMID: 32492084 Free PMC article. Clinical Trial.
Similar articles
-
Why should we use convalescent plasma for COVID-19?Eur J Intern Med. 2020 Jul;77:150-151. doi: 10.1016/j.ejim.2020.05.019. Epub 2020 May 16. Eur J Intern Med. 2020. PMID: 32425365 Free PMC article. No abstract available.
-
Convalescent plasma for patients with COVID-19.Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12528. doi: 10.1073/pnas.2006961117. Epub 2020 May 12. Proc Natl Acad Sci U S A. 2020. PMID: 32398379 Free PMC article. No abstract available.
-
Convalescent plasma for covid-19.BMJ. 2020 Sep 15;370:m3516. doi: 10.1136/bmj.m3516. BMJ. 2020. PMID: 32933945 No abstract available.
-
COVID-19: Main therapeutic options.Tunis Med. 2020 Apr;98(4):299-303. Tunis Med. 2020. PMID: 32395792 Review. No abstract available.
-
Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.Eur J Immunol. 2020 Oct;50(10):1447-1453. doi: 10.1002/eji.202048723. Epub 2020 Sep 22. Eur J Immunol. 2020. PMID: 32886952 Review.
Cited by
-
[Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)].Med Intensiva. 2021 Mar;45(2):104-121. doi: 10.1016/j.medin.2020.06.017. Epub 2020 Jul 11. Med Intensiva. 2021. PMID: 38620757 Free PMC article. Spanish.
-
Blood-derived product therapies for SARS-CoV-2 infection and long COVID.MedComm (2020). 2023 Nov 15;4(6):e426. doi: 10.1002/mco2.426. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38020714 Free PMC article. Review.
-
Exercise and Experiments of Nature.Compr Physiol. 2023 Jun 26;13(3):4879-4907. doi: 10.1002/cphy.c220027. Compr Physiol. 2023. PMID: 37358508 Free PMC article.
-
Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children's Hospital: A Contribution to a Still Inadequate Body of Evidence.Children (Basel). 2023 Feb 10;10(2):350. doi: 10.3390/children10020350. Children (Basel). 2023. PMID: 36832478 Free PMC article.
-
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications.Front Immunol. 2023 Jan 19;14:1055457. doi: 10.3389/fimmu.2023.1055457. eCollection 2023. Front Immunol. 2023. PMID: 36742320 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
